AbbVie Inc.·4

Mar 3, 6:12 PM ET

Michael Robert A. 4

4 · AbbVie Inc. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

AbbVie (ABBV) CEO Michael Robert A. Sells 36,523 Shares (Tax Withholding)

What Happened

  • Michael Robert A., Chairman of the Board and CEO of AbbVie (ABBV), reported a disposition of 36,523 shares on 2026-02-27 to satisfy an exercise price or tax liability. The shares were valued at $232.08 each, for a total of approximately $8,476,258.
  • This transaction is reported as tax withholding (code F), meaning shares were surrendered/withheld to cover tax obligations — a routine administrative action rather than an open-market sale intended as investment signaling.

Key Details

  • Transaction date: 2026-02-27; Filed with the SEC: 2026-03-03 (appears to be filed within the usual 2-business-day window).
  • Price per share: $232.08; Shares involved: 36,523; Total value: ~$8,476,258.
  • Transaction code: F — Payment of exercise price or tax liability (sell-to-cover/withholding).
  • Post-transaction shares owned: Not provided in the data you supplied (not disclosed here).
  • No indication in this report that shares were sold on the open market; this was a tax-withholding disposition.

Context

  • Tax-withholding dispositions are common when stock grants vest or options are exercised; they are administrative and don’t necessarily reflect the insider’s view on the company’s stock. For retail investors, purchases by insiders tend to be more informative than routine withholding or gift-related dispositions.

Insider Transaction Report

Form 4
Period: 2026-02-27
Michael Robert A.
DirectorCHAIRMAN OF THE BOARD AND CEO
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2026-02-27$232.08/sh36,523$8,476,258178,737 total
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Robert A. Michael|2026-03-03

Documents

1 file
  • 4
    form4-03032026_110308.xmlPrimary